No CrossRef data available.
Article contents
Fatal pharmacokinetic interaction involving amitriptyline combined with valproate and clozapine
Published online by Cambridge University Press: 13 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Letter to the Editor
- Information
- Copyright
- Copyright © Cambridge University Press 1998
References
1.Pounder, DJ, Owen, V, Qtiigley, C. Post mortem changes in Monti Dmitri pry line concentration. Am J E-orensic Path 1994; 15: 224–30.CrossRefGoogle Scholar
2.Prcskorn, SH. Tricyclic antidepressants: the whys and hows of therapeutic monitoring. J Clin Psychiatry 1994; 34(7):34–42.Google Scholar
3.Wong, SL, Cuvanaugh, J, Shi, Het al.Effects of divalproex sodium on anutriptvline and nortriptyline pharmacokinetics. Clin Pharmacol Ther 1996; 60: 48–53.CrossRefGoogle ScholarPubMed
4.Smith, T, Riskin, J, Effect of clozapine on plasma nortriptyline concentration. Pharmacopsychiatry 1994; 27; 41–2.CrossRefGoogle ScholarPubMed
5.Bertz, RJ, Granneman, GR. Use of in vitro and in vivo data to estimate the likelihood ol metabolic pharmacokinetic interactions. Clin Pharmacokinetics 1997:32:210–58.CrossRefGoogle Scholar
You have
Access